NCT07664826 Acupuncture Mechanism in Relief of Gag Reflex
| NCT ID | NCT07664826 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Medicine Greifswald |
| Condition | Gag (Pharyngeal) Reflex |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-01-21 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-01-21 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The gag reflex relief effect of acupuncture of CV24 acupoint will be compared to acupuncture of PC6 and K3 acupoints in healthy volunteers in crossover mode. Second step will be the investigation whether local anesthesia using EMLA creme will block the gag relief effect of CV24 acupuncture in healthy volunteers.
Eligibility Criteria
Inclusion Criteria: 1. Healthy volunteers aged between 20-40 years old with an American Society of Anesthesiologists physical status of I to II naïve to acupuncture 2. Participants without previous opioid and psychotropic medication 3. Without use of recreational drugs 3 days prior to study sessions 4. Without systemic disease or local skin lesions at the sites of acupuncture 5. Without drug allergy to local anesthetics, especially EMLA preparation 6. Participants who have given written informed consent Exclusion Criteria: 1. Local skin infection at the sites of acupuncture 2. Aged \< 20 or \> 35 years 3. History of drug allergy to local anesthetics 4. Participants who are unable to understand the consent form or to use numeric rating scale NRS-11 Discontinuation Criteria 1. Any adverse effects during study session 2. In case of local or systemic infection 3. In case if subject will withdraw from participation in this study at any time, for any reason, specified or non-specified, and without penalty or loss of benefits
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07664826 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 40 Years, studying Gag (Pharyngeal) Reflex. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07664826 currently recruiting?
Yes, NCT07664826 is actively recruiting participants. Contact the research team at tarasik@me.com for enrollment information.
Where is the NCT07664826 trial being conducted?
This trial is being conducted at Greifswald, Germany.
Who is sponsoring the NCT07664826 clinical trial?
NCT07664826 is sponsored by University Medicine Greifswald. The trial plans to enroll 30 participants.